Svitlana V. Andreieva
04075, Ukraine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma.
Journal: Experimental oncology
Published: December 30, 2021
Peculiarities of abnormal karyotypes formation in therapy-related acute leukemias.
Journal: Experimental oncology
Published: July 01, 2020
Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Journal: Experimental oncology
Published: February 28, 2018
Chronic myeloid leukemia in patient with the Klinefelter syndrome.
Journal: Experimental oncology
Published: September 30, 2016
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.
Journal: Cancer cell international
Published: November 18, 2015
mTOR inhibitor temsirolimus and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type-dependent phenotype changes of glioblastoma cells.
Journal: Gene
Published: October 27, 2015
Step-wise and punctuated genome evolution drive phenotype changes of tumor cells.
Journal: Mutation research
Published: July 08, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026